Real-Time Single-Cell Measurement and Kinetic Modeling of Daunorubicin Uptake in Multidrug Resistant Leukemia Cells Using a Microfluidic Biochip
Preprint
- 11 February 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Multidrug resistance (MDR) remains a major pathophysiological barrier to effective anthracycline-based chemotherapy, including daunorubicin (DNR), in the treatment of leukemia. However, population-level measurements of drug uptake do not resolve variability in uptake kinetics among individual leukemia cells, which may influence intracellular drug accumulation and therapeutic response. In this study, real-time DNR uptake was quantified at the single-cell level using a microfluidic biochip that enabled long-term cellular retention and continuous monitoring. Both wild-type drug-sensitive leukemia cells and a multidrug-resistant mutant overexpressing the P-glycoprotein (P-gp) efflux pump were examined. Kinetic analysis revealed that DNR uptake in drug-sensitive cells was well described by a single dominant uptake process, whereas uptake in MDR cells required a model incorporating two kinetically distinct processes. In both cell populations, pronounced cell-to-cell variation was observed in uptake rates and intracellular drug retention, indicating substantial functional heterogeneity within phenotypically similar cells. This variability persisted following treatment with an MDR inhibitor and obscured differences between inhibitor-treated and untreated cells when uptake was compared across different single cells. To overcome this limitation, a same-single-cell analysis (SASCA) approach was employed, enabling direct comparison of DNR uptake in the same individual cell before and after inhibitor exposure, thereby revealing enhanced intracellular DNR retention and accelerated uptake kinetics following inhibition. Together, these results demonstrate that real-time single-cell kinetic analysis reveals functionally relevant heterogeneity in multidrug-resistant leukemia cells and provides insight into the pathophysiology of MDR that cannot be obtained from population-averaged measurements.Keywords
All Related Versions
- Version 1, 2026-02-11, Preprints
- Published version: Pathophysiology, 33 (2), 28.
This publication has 26 references indexed in Scilit:
- LDLR-targeted orlistat therapeutic nanoparticles: Peptide selection, assembly, characterization, and cell-uptake in breast cancer cell linesInternational Journal of Pharmaceutics, 2025
- Discrimination of Multidrug Resistance in Cancer Cells Achieved Using Single-Cell Analysis2023
- Assessing the growth kinetics and stoichiometry of Escherichia coli at the single‐cell levelEngineering in Life Sciences, 2022
- A review of developments and applications of thin‐film microextraction coupled to surface‐enhanced Raman scatteringElectrophoresis, 2019
- Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulationAnalytical and Bioanalytical Chemistry, 2014
- The dynamics of drug resistance: A mathematical perspectiveDrug Resistance Updates, 2012
- Single-Cell-Kinetics Approach to Compare Multidrug Resistance-Associated Membrane Transport in Subpopulations of CellsAnalytical Chemistry, 2011
- Same-Single-Cell Analysis for the Study of Drug Efflux Modulation of Multidrug Resistant Cells Using a Microfluidic ChipAnalytical Chemistry, 2008
- The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein researchFEBS Letters, 2005
- Inactivation of bacteria and spores by pulse electric field and high pressure CO2 at low temperatureBiotechnology and Bioengineering, 2003